Position in ABBV
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$106,244,168
+$14,624,984 QoQ
Shares Held
422,207
+0.2% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
#246
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glenview Trust Co holds $465,808,551 across 12 Drug Manufacturers - General names. ABBV ranks #2 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
188,484 | $226,073,382 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
422,207 | $106,244,168 | |
| 3 | MRK |
Merck & Co., Inc.
|
381,609 | $49,036,756 | |
| 4 | JNJ |
Johnson & Johnson
|
150,964 | $38,340,326 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
195,795 | $24,736,739 | |
| 6 | PFE |
Pfizer Inc
|
442,787 | $10,662,310 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
102,223 | $5,890,089 | |
| 8 | AMGN |
Amgen Inc
|
8,321 | $3,013,200 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,244,168 | 422,207 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $91,619,184 | 421,257 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $94,898,065 | 415,327 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $95,892,058 | 414,149 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $78,234,931 | 421,479 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $86,554,596 | 413,109 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $73,058,689 | 411,135 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $80,931,450 | 409,821 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $69,833,167 | 407,143 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $73,675,110 | 404,586 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $60,719,414 | 391,814 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $56,188,763 | 376,954 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $48,744,908 | 361,797 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $56,901,145 | 357,038 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $57,161,780 | 353,702 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $46,493,430 | 346,423 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $52,183,296 | 340,711 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $54,415,301 | 335,669 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $42,226,791 | 311,867 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $34,344,729 | 318,390 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $34,359,705 | 305,040 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $20,417,866 | 188,670 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $19,935,149 | 186,049 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $16,281,842 | 185,887 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $18,407,866 | 187,491 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $14,242,043 | 186,928 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||